Chara is a Principal PBPK Scientist in the PBPK Consultancy group at Certara Predictive Technologies. She brings extensive experience across PBPK–PD, DMPK & clinical pharmacology oversight, supporting drug development & regulatory submissions from early discovery to clinical & post-market stages. She’s a strong advocate for integrating PBPK modelling with strategic clinical pharmacology to optimize clinical study design & streamline the drug development process.